| Cord Blood America Updates Investors on First Quarter 2010 Achievements (PR Newswire) Cord Blood America, Inc. , the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that its co-founder and CEO, Matthew Schissler, reviewed first quarter results and progress in an interview with analyst Francis Gaskins. us.rd.yahoo.com |
Drug-Benefits Fights Loom Navistar's plan to drop some retirees' prescription benefits is turning into a skirmish that is likely to be replayed at other U.S. companies. online.wsj.com |
Seven Companies Complete IPOs This Week, Already Facing Pricing Pressure Renaissance Capital IPO Research submits: A total of seven companies came to market this week, the highest weekly number in roughly three months. However, all seven deals priced below the midpoints of their proposed ranges and trading was lackluster, indicating the IPO market remains shaky after months of broader market volatility. Leading semiconductor company NXP (NXPI) priced its 34 million shares at $14, below the $18-$21 range. With $475 million in gross proceeds, the KKR and Bain-sponsored deal was the fourth largest IPO year-to-date. The former carve-out of Philips fell roughly -2% in its early trading on Friday, which was not surprising given its highly leveraged balance sheet and the lackluster trading by other PE-backed deals. Complete Story » seekingalpha.com |
Allergan to Settle Botox Charges Allergan agreed to pay the U.S. government $600 million to settle criminal and civil charges related to the marketing of antiwrinkle treatment Botox. online.wsj.com |
Theravance Inc. CEO Discusses Q3 2010 Results - Earnings Call Transcript Theravance Inc. (THRX) Q3 2010 Earnings Call October 21, 2010 5:00 pm ETComplete Story » seekingalpha.com |